(StatePoint) Getting the correct treatment for bronchiectasis, a chronic lung condition affecting 350,000 to 500,000 adults nationwide, is necessary to slow disease progression and help prevent further damage to the airways.

The American Lung Association, with support from Boehringer Ingelheim, is raising awareness about the need for early diagnosis and treatment of bronchiectasis. Here are the top things to know: ×

This page requires Javascript.

Javascript is required for you to be able to read premium content. Please enable it in your browser settings. kAmkDEC@?8mqC@?49:64E2D:D :D 49C@?:4]k^DEC@?8m qC@?49:64E2D:D :D 2 =:76=@?8[ AC@8C6DD:G6 =F?8 4@?5:E:@? H96C6 E96 H2==D @7 J@FC 2:CH2JD W3C@?49:X 2C6 A6C>2?6?E=J 52>2865[ 364@>:?8 H:56?65 2?5 E9:4<6?65 7C@> :?7=2>>2E:@? 2?5 :?764E:@

See Full Page